Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital, Ghent |
---|---|
Information provided by: | University Hospital, Ghent |
ClinicalTrials.gov Identifier: | NCT00117416 |
The purpose of this study is to evaluate the renal perfusion depending on the MAP.
Condition | Intervention |
---|---|
Kidney Failure, Acute |
Procedure: controlling the MAP |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Crossover Assignment, Efficacy Study |
Official Title: | MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2002/382 |
Study First Received: | June 30, 2005 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00117416 History of Changes |
Health Authority: | Belgium: Directorate general for the protection of Public health: Medicines |
Renal Insufficiency Urologic Diseases Critical Illness Renal Insufficiency, Acute |
Kidney Diseases Kidney Failure, Acute Kidney Failure |
Renal Insufficiency Disease Attributes Pathologic Processes Urologic Diseases Critical Illness |
Renal Insufficiency, Acute Kidney Diseases Kidney Failure, Acute Kidney Failure |